Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Adenuric (febuxostat) - Important Safety Information from Menarini as approved by the Irish Medicines Board
Notice type:
3rd Party Publications
Date:
21/05/2012
Problem Or Issue:
Important Safety Information communication from Menarini on the association of the risk of serious hypersensitivity reactions, including Stevens-Johnson Syndrome and acute anaphylactic reaction/shock, with Adenuric (febuxostat).
Important Safety Information - Adenuric (febuxostat)
« Back
Date Printed: 03/05/2024